Items without sitelinks
From determinar.ia.br - Determine suas informações
Showing below up to 50 results in range #9,951 to #10,000.
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Psychotropic drugs, not elsewhere classified, Psychodysleptics (Q102859)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Loop diuretics (Q102858)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Electrolytic, caloric or water-balance agents (Q102857)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Psychotropic drugs, not elsewhere classified, Tricyclic or tetracyclic antidepressants (Q102856)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Mineral salts, not elsewhere classified (Q102855)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Agents affecting uric acid metabolism (Q102854)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Carbonic-anhydrase inhibitors (Q102853)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Benzothiadiazine derivatives (Q102852)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Other diuretics (Q102851)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Mineralocorticoids (Q102850)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Psychotropic drugs, not elsewhere classified, Other antipsychotics or neuroleptics (Q102849)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Mineralocorticoid antagonists (Q102848)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Agents affecting calcification (Q102847)
- Drugs medicaments or biological, substances associated with injury or harm in therapeutic use, Psychotropic drugs, not elsewhere classified, Monoamine-oxidase-inhibitor antidepressants (Q102846)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Psychotropic drugs, not elsewhere classified, Butyrophenone or thioxanthene neuroleptics (Q102845)
- Duration of pregnancy 41 completed weeks (Q102844)
- O60 (Q102843)
- K64.5 (Q102842)
- C85.2 (Q102841)
- Duration of pregnancy 42 completed weeks (Q102840)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other systemic anti-infectives or antiparasitics, Antiviral drugs (Q102839)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Psychotropic drugs, not elsewhere classified, Other or unspecified antidepressants (Q102838)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other systemic anti-infectives or antiparasitics, Other specified systemic anti-infectives or antiparasitics (Q102837)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system, Calcium-channel blockers (Q102836)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Central nervous system stimulants, not elsewhere classified, Opioid receptor antagonists (Q102835)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system, Coronary vasodilators, not elsewhere classified (Q102834)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system, Peripheral vasodilators (Q102833)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other systemic anti-infectives or antiparasitics, Antimalarials or drugs acting on other blood protozoa (Q102832)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system, Angiotensin-converting-enzyme inhibitors (Q102831)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other systemic anti-infectives or antiparasitics, Other antiprotozoal drugs (Q102830)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system, Antivaricose drugs, including sclerosing agents (Q102829)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other systemic anti-infectives or antiparasitics, Anthelminthics (Q102828)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other systemic anti-infectives or antiparasitics, Sulfonamides (Q102827)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system, Other antihypertensive drugs, not elsewhere classified (Q102826)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Central nervous system stimulants, not elsewhere classified, Analeptics (Q102825)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Central nervous system stimulants, not elsewhere classified, Methylxanthines, not elsewhere classified (Q102824)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system, Antihyperlipidaemic or antiarteriosclerotic drugs (Q102823)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other systemic anti-infectives or antiparasitics, Antimycobacterial drugs (Q102822)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the gastrointestinal system, Antidiarrhoeal drugs (Q102821)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system, Other antidysrhythmic drugs, not elsewhere classified (Q102820)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system, Cardiac-stimulant glycosides or drugs of similar action (Q102819)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the gastrointestinal system, Emetics (Q102818)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the gastrointestinal system, Digestants (Q102817)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the gastrointestinal system, Stimulant laxatives (Q102816)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Antiepileptics or antiparkinsonism drugs, Other or unspecified antiepileptics (Q102815)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the gastrointestinal system, Saline or osmotic laxatives (Q102814)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the gastrointestinal system, Other laxatives (Q102813)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Hormones or their synthetic substitutes or antagonists, not elsewhere classified, Androgens or anabolic congeners (Q102812)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Hormones or their synthetic substitutes or antagonists, not elsewhere classified, Other estrogens or progestogens (Q102811)
- Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Antiepileptics or antiparkinsonism drugs, Iminostilbenes (Q102810)
